Comparison |
| Alternate Manufacturer Number |
| 1208263 | 2057016 | 1965789 | 1648823 |
| Alternate Packaging |
| BX/25 | | | |
| Container Type |
Carton | Single-Dose Vial | Single-Dose Vial | Multiple-Dose Vial | Bottle |
| Country of Origin |
Unknown | United States | Unknown | Unknown | Unknown |
| Dosage Form |
Implant | Injection | Injection | Injection | Solution |
| Generic Drug Code |
27558 | 27350 | 27354 | 27354 | 33806 |
| Generic Drug Name |
Dexamethasone | Dexamethasone Sodium Phosphate | Dexamethasone Sodium Phosphate | Dexamethasone Sodium Phosphate | Prednisolone Sodium Phosphate |
| NDC Number |
00023334807 | 00641036725 | 67457042312 | 63323016530 | 00121075908 |
| Product Dating |
| McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 30 days | McKesson Acceptable Dating: we will ship >= 90 days |
| Quantity |
1 Implant | | | | |
| Strength |
0.7 mg | 10 mg / mL | 4 mg / mL | 4 mg / mL | 15 mg / 5 mL |
| Type |
Intravitreal | Intramuscular or Intravenous | Intramuscular or Intravenous | Intramuscular or Intravenous | Oral |
| UNSPSC Code |
51422306 | 51422342 | 51422342 | 51422342 | 51422315 |
| Volume |
| 1 mL | 1 mL | 30 mL | 237 mL |
| Application |
Adrenal | Adrenal | Adrenal | Adrenal | Adrenal |
| Features and Benefits |
- Used to treat adults with macular edema following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO)
- OZURDEX® (dexamethasone intravitreal implant) 0.7 mg is supplied in a foil pouch with 1 single-use plastic applicator
|
- Generic Equivalent to Decadron®
|
- For Intravenous, Intramuscular, Intra-articular, Soft Tissue, or Intralesional Use
|
- Multiple dose amber vial
- Bar Coded
|
- Grape Flavor
- Keep tightly closed and out of the reach of children
|
